Esperion Therapeutics, Inc. (NASDAQ: ESPR) Stock Information | RedChip

Esperion Therapeutics, Inc. (NASDAQ: ESPR)


$2.2900
+0.0500 ( +2.23% ) 1.7M

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Market Data


Open


$2.2900

Previous close


$2.2400

Volume


1.7M

Market cap


$435.45M

Day range


$2.1870 - $2.2850

52 week range


$1.5800 - $3.9400

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Dec 18, 2024
4 Insider transactions 2 Dec 18, 2024
4 Insider transactions 2 Dec 18, 2024
8-k 8K-related 20 Dec 18, 2024
8-k 8K-related 15 Dec 13, 2024
4 Insider transactions 2 Nov 20, 2024
10-q Quarterly Reports 73 Nov 07, 2024
8-k 8K-related 14 Nov 07, 2024
4 Insider transactions 2 Oct 18, 2024
4 Insider transactions 1 Sep 18, 2024

Latest News